Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 19 de 19
3.
J Infect Chemother ; 25(5): 368-370, 2019 May.
Article En | MEDLINE | ID: mdl-30686700

The significance of anaerobic bacteria as a pathogen in urinary tract infection (UTI) in children is unclear. A two-month-old infant presenting with poor feeding received a diagnosis of polymicrobial anaerobic UTI by next-generation sequencing and was found to have obstructive uropathy. Anaerobic bacteria may be a cause of UTI in children with urinary tract obstruction.


Anti-Bacterial Agents/therapeutic use , Bacteria, Anaerobic/isolation & purification , Prevotella melaninogenica/isolation & purification , Pyonephrosis/microbiology , Urinary Tract Infections/microbiology , Drug Therapy, Combination , Female , Humans , Infant , Pyonephrosis/diagnostic imaging , Pyonephrosis/therapy , Pyonephrosis/urine , Treatment Outcome , Ultrasonography , Urinary Catheterization , Urinary Tract Infections/diagnostic imaging , Urinary Tract Infections/therapy , Urinary Tract Infections/urine
6.
Mol Med Rep ; 16(3): 3528-3534, 2017 Sep.
Article En | MEDLINE | ID: mdl-28765918

Pyelonephritis is an infection of the upper urinary tract with characteristic histological change to neutrophil infiltration in the kidney. The majority of pyelonephritis is caused by uropathogenic Escherichia (E.) coli (UPEC) bearing distinct virulence factors. Toll/interleukin­1 receptor domain­containing protein C (TcpC) encoded by E. coli is an important virulence factor in the majority of strains of UPEC and inhibits macrophage­mediated innate immunity, which serves an essential role in the pathogenesis of pyelonephritis. In the present study, it was demonstrated that TcpC induced kidney cells to produce macrophage inflammatory protein­2 (MIP­2; also known as C­X­C motif chemokine 2). MIP­2 concentration in kidney homogenates from TcpC­secreting UPEC CFT073 (TcpCwt) murine pyelonephritis models was significantly higher compared with that in kidney homogenates from tcpC knockout CFT073 (TcpC­/­) models. In vitro, TcpCwt dose­dependently promoted MIP­2 secretion in HEK­293 cells. The concentration of MIP­2 in culture supernatants of HEK­293 co­cultured with TcpCwt was profoundly higher compared with that of HEK­293 co­cultured with TcpC­/­. In the presence of anti­TcpC antibody, the enhancement effect of TcpCwt on MIP­2 production was completely abrogated, suggesting that the enhanced production of MIP­2 was mediated by secreted TcpC. Furthermore, it was demonstrated that TcpC­/­ treatment had no effect on the p38 mitogen activated protein kinase (MAPK) signaling pathway, while TcpCwt treatment resulted in the activation of p38 MAPK in HEK­293 cells, as indicated by a simultaneous increase in p38 and phosphorylated­p38. In addition, inhibition of p38 MAPK with SB203580 significantly decreased MIP­2 concentration and neutrophil recruitment activity in the supernatants of HEK­293 cells co­cultured with TcpCwt. This indicates that TcpC may promote MIP­2 production in kidney cells through the p38 MAPK signaling pathway. Taken together, the data of the present study demonstrated that TcpC can induce MIP­2 production, which may contribute to the characteristic histological change associated with pyelonephritis. This data has provided novel evidence to further clarify the pathogenesis of pyelonephritis and novel directions on the pathogenicity of TcpC­secreting UPEC.


Chemokine CXCL2/metabolism , Escherichia coli Proteins/metabolism , MAP Kinase Signaling System , Uropathogenic Escherichia coli/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Escherichia coli Infections/metabolism , Escherichia coli Infections/pathology , HEK293 Cells , Humans , Mice , Mice, Knockout , Pyonephrosis/metabolism , Pyonephrosis/microbiology , Pyonephrosis/pathology , Virulence Factors
7.
Anaerobe ; 40: 15-7, 2016 Aug.
Article En | MEDLINE | ID: mdl-27112422

Herein we report two cases of infections caused by Tissierella praeacuta and a review of the literature. The first case was a septic pseudarthrosis of the left femur after multiple fractures. Two per-operative samples were positive with T. praeacuta. The patient was successfully treated by piperacillin - tazobactam and metronidazole. The second case was a bacteremia in a patient suffering from pyonephrosis and a hepatic abscess. The treatment was meropenem. No relapses were observed in both cases. Identification of the strains using MALDI-TOF coupled to mass spectrometry (MS) (Beckman coulter, France) was inconclusive in the two cases. Identification by 16S rRNA sequencing was then performed. This bacterium was susceptible to beta-lactams, chloramphenicol, rifampicine and metronidazole.


Bacteremia/diagnosis , Femoral Neck Fractures/diagnosis , Firmicutes/isolation & purification , Liver Abscess/diagnosis , Pseudarthrosis/diagnosis , Pyonephrosis/diagnosis , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/complications , Bacteremia/drug therapy , Bacteremia/microbiology , Bacterial Typing Techniques , Femoral Neck Fractures/complications , Femoral Neck Fractures/drug therapy , Femoral Neck Fractures/microbiology , Femur/microbiology , Femur/pathology , Firmicutes/genetics , Humans , Liver Abscess/complications , Liver Abscess/drug therapy , Liver Abscess/microbiology , Meropenem , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Polymerase Chain Reaction , Pseudarthrosis/complications , Pseudarthrosis/drug therapy , Pseudarthrosis/microbiology , Pyonephrosis/complications , Pyonephrosis/drug therapy , Pyonephrosis/microbiology , RNA, Ribosomal, 16S/genetics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Thienamycins/therapeutic use , Treatment Outcome
9.
Urol Int ; 96(2): 241-3, 2016.
Article En | MEDLINE | ID: mdl-25115408

INTRODUCTION: Salmonella is a rare cause of urinary tract infections. We report here a unique case of pyonephrosis due to Salmonella Typhi (S. Typhi) complication, a stone-related obstructive pyelonephritis. CASE REPORT: A 47-year-old man, without any history of typhoid fever or gastrointestinal symptoms, presented with a pyonephrosis and life-threatening bacteremia following an acute obstructive right pyelonephritis caused by S. Typhi. The patient was treated by urinary drainage (ureteral stent), antibiotics, and delayed right nephrectomy. We postulated that urolithiasis could explain asymptomatic chronic urinary carriage of S. Typhi. CONCLUSION: S. Typhi is one possible cause of life-threatening urinary tract infection, especially in the context of urolithiasis.


Pyelonephritis/microbiology , Pyonephrosis/microbiology , Salmonella typhi/isolation & purification , Typhoid Fever/microbiology , Urinary Tract Infections/microbiology , Urolithiasis/microbiology , Anti-Bacterial Agents , Drainage/instrumentation , Humans , Male , Middle Aged , Nephrectomy , Pyelonephritis/diagnosis , Pyelonephritis/therapy , Pyonephrosis/diagnosis , Pyonephrosis/therapy , Stents , Tomography, X-Ray Computed , Treatment Outcome , Typhoid Fever/diagnosis , Typhoid Fever/therapy , Urinary Tract Infections/diagnosis , Urinary Tract Infections/therapy , Urine/microbiology , Urolithiasis/diagnosis , Urolithiasis/therapy
10.
Indian J Med Microbiol ; 33(2): 311-3, 2015.
Article En | MEDLINE | ID: mdl-25865994

Chryseobacterium spp are widely distributed in nature but data of their isolation from clinical samples is scanty. Here, we report the first case of AmpC producing C. gleum causing pyonephrosis in a patient having bilateral nephrolithiasis on double J (DJ) stent. The present isolate was resistant to vancomycin, erythromycin, clindamycin, carbapenems and ciprofloxacin and susceptible to tetracycline and minocycline. The patient was treated with tetracycline and recovered without the need for removal of the DJ stent. The environmental surveillance carried out to trace the nosocomial origin of the isolate was negative. Since antimicrobial susceptibility of this isolate is different from previous reports, we emphasise that in vitro susceptibility testing should be sought to choose optimal antimicrobial agents for these Nonfermentative Gram-Negative Bacilli (NFGNBs) with different susceptibility patterns.


Chryseobacterium/isolation & purification , Flavobacteriaceae Infections/diagnosis , Flavobacteriaceae Infections/pathology , Nephrolithiasis/complications , Pyonephrosis/diagnosis , Pyonephrosis/pathology , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Chryseobacterium/drug effects , Chryseobacterium/enzymology , Drug Resistance, Multiple, Bacterial , Flavobacteriaceae Infections/drug therapy , Flavobacteriaceae Infections/microbiology , Humans , Male , Middle Aged , Pyonephrosis/drug therapy , Pyonephrosis/microbiology , Tetracycline/administration & dosage , Treatment Outcome , beta-Lactamases/metabolism
11.
Urol Int ; 94(4): 436-41, 2015.
Article En | MEDLINE | ID: mdl-25661913

INTRODUCTION: To evaluate therapeutic results till 5 years after therapy of obstructive pyelonephritis (OPN) emphasizing regular follow-up. MATERIAL AND METHODS: During 5 years, 57 patients with OPN were treated. The patients' charts were reviewed retrospectively for clinical data. These were completed by a questionnaire. RESULTS: In the group of 57 patients (average age 56 years), about two third were women. Urolithiasis (65%) and tumors (21%) were the main causes of obstruction; fever (91%) and loin pain (86%) the main symptoms. Three fourth of the patients showed renal insufficiency and nearly 50% anemia. E. coli and Proteus spp. were the dominating organisms. Sonography detected obstruction in 93% cases. In one third of cases, CT scan was added; 81% percutaneous nephrostomy and 19% ureteral stenting were the initial methods of urinary drainage. During therapy, 23% nephrectomies (19% complete, 4% partial) were performed. Long-term follow-up showed 11% recurrent OPN and 33% recurrent UTI. CONCLUSIONS: After diagnosis of OPN, primary nephrostomy or ureteral stenting and antibiotic therapy are the first measures. If recurrent urinary tract infections or OPN occur, long-term follow-up and low-dose antibiotic prophylaxis may be discussed.


Anti-Bacterial Agents/therapeutic use , Nephrectomy , Nephrostomy, Percutaneous , Pyelonephritis/therapy , Pyonephrosis/therapy , Urinary Diversion , Urinary Tract Infections/therapy , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Child , Drainage/adverse effects , Drainage/instrumentation , Female , Humans , Male , Middle Aged , Nephrectomy/adverse effects , Nephrostomy, Percutaneous/adverse effects , Nephrostomy, Percutaneous/instrumentation , Pyelonephritis/diagnosis , Pyelonephritis/microbiology , Pyonephrosis/diagnosis , Pyonephrosis/microbiology , Recurrence , Retrospective Studies , Risk Factors , Stents , Time Factors , Treatment Outcome , Urinary Diversion/adverse effects , Urinary Tract Infections/diagnosis , Urinary Tract Infections/microbiology , Urolithiasis/complications , Urolithiasis/therapy , Urologic Neoplasms/complications , Urologic Neoplasms/therapy , Young Adult
12.
Int Urol Nephrol ; 47(2): 229-33, 2015 Feb.
Article En | MEDLINE | ID: mdl-25425439

BACKGROUND: Urinary tract infections are a common problem encountered by primary care, emergency physicians and urologists. A complicated urinary tract infection (CUTI) responds less effectively to the standard treatment. E. coli is the most common pathogen (40-70 %). In Mexico, there are ciprofloxacin resistance rates of 8-73 %, to trimethoprim/sulfamethoxazole 53-71 % and cephalosporins 5-18 %, with an ESBL E. coli prevalence of 10 %. For infections producing gas or purulent material, the percutaneous or endoscopic drainage is the standard. OBJECTIVE: To describe the management of patients with CUTIs, their specifically clinical course and eventual culture results determining the most common isolated microorganisms and their resistance. MATERIALS AND METHODS: The clinical records of patients hospitalized with CUTIs from January 2012 to July 2013 were reviewed. RESULTS: One hundred and seventy-three patients were included. Acute pyelonephritis was the most common presentation (53.2 %). The most common microorganism was E. coli (83 %), with ESBL prevalence of 71.4 % and a resistance to quinolone, cephalosporin and trimethoprim of 89.7, 64.7 and 60.3 %, respectively. The most common factors associated with development of CUTIs were recent use of antibiotics (95.3 %) and obstructive uropathy (73.4 %). A total of 41 % received carbapenems and 40.5 % received minimally invasive treatments. Overall mortality was 2.9 %. DISCUSSION: There were a greater ESBL-producing pathogen prevalence and an over 50 % resistance to classically first-choice antibiotics. The minimally invasive treatments for complicated infections are fundamental; however, nephrectomy still has a role. CONCLUSIONS: Wide-spectrum antimicrobial therapy and minimally invasive approaches are the most common treatments for CUTIs in our center, and a reevaluation regarding antibiotic use in Mexico needs to be done.


Abscess , Anti-Bacterial Agents/therapeutic use , Escherichia coli Infections/diagnosis , Escherichia coli , Urinary Tract Infections/drug therapy , Abscess/microbiology , Abscess/therapy , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Drug Resistance, Multiple, Bacterial , Epididymitis/microbiology , Epididymitis/therapy , Escherichia coli/metabolism , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Female , Humans , Length of Stay , Male , Mexico , Middle Aged , Orchitis/microbiology , Orchitis/therapy , Prostatitis/microbiology , Prostatitis/therapy , Pyelonephritis/microbiology , Pyelonephritis/therapy , Pyonephrosis/microbiology , Pyonephrosis/therapy , Risk Factors , Stents , Urinary Tract Infections/complications , Urinary Tract Infections/microbiology , Young Adult , beta-Lactamases/metabolism
14.
Int Urol Nephrol ; 45(4): 939-42, 2013 Aug.
Article En | MEDLINE | ID: mdl-22907630

Pyonephrosis is uncommon in adult and paediatric population and very rare in neonates. Neonatal candidal and staphylococcal pyonephrosis has been reported earlier, and this is the first reported case of MRSA pyonephrosis. A case of potentially lethal fulminating primary MRSA pyonephrosis with septic shock in a neonate in whom investigations showed refluxing and obstructing left megaureter requiring successful surgical correction has been reported.


Methicillin-Resistant Staphylococcus aureus/isolation & purification , Nephrostomy, Percutaneous/methods , Pyonephrosis/therapy , Shock, Septic/therapy , Staphylococcal Infections/diagnosis , Anti-Bacterial Agents/therapeutic use , Blood/microbiology , Combined Modality Therapy , Critical Illness , Follow-Up Studies , Humans , Infant, Newborn , Male , Pyonephrosis/diagnosis , Pyonephrosis/microbiology , Radiography , Rare Diseases , Risk Assessment , Shock, Septic/complications , Shock, Septic/diagnosis , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Treatment Outcome , Ultrasonography, Doppler , Ureteral Obstruction/diagnostic imaging , Ureteral Obstruction/etiology , Ureteral Obstruction/surgery , Urinalysis , Vesico-Ureteral Reflux/diagnostic imaging , Vesico-Ureteral Reflux/etiology , Vesico-Ureteral Reflux/therapy
16.
Am J Med Sci ; 338(3): 233-5, 2009 Sep.
Article En | MEDLINE | ID: mdl-19636241

In this article, we describe the first, to our knowledge, reported case of severe bacteremic upper urinary tract infection with pyonephrosis-in the context of prior chronic urinary tract disease-caused by community-acquired methicillin-resistant Staphylococcus aureus (MRSA). The patient presented with fever and constitutional symptoms, and computed tomography revealed extensive renal parenchymal infection along with a staghorn calculus and dilatation of the pyelocalyceal system. His clinical condition rapidly deteriorated, and he developed uncontrollable sepsis, necessitating an emergent nephrectomy. Significant pyonephrosis was noted during surgery. Blood cultures yielded MRSA, and molecular analysis (by polymerase chain reaction) of the MRSA strains from blood and wound fluid showed that they were Panton-Valentine leukocidin positive and they also possessed SCCmecA type IV. Postoperatively, the patient was treated with intravenous vancomycin for 3 weeks and had a favorable outcome.


Community-Acquired Infections/microbiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Pyelonephritis/diagnosis , Pyelonephritis/microbiology , Pyonephrosis/diagnosis , Pyonephrosis/microbiology , Staphylococcal Infections/microbiology , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/complications , Humans , Male , Pyelonephritis/drug therapy , Pyonephrosis/drug therapy , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use
18.
Saudi J Kidney Dis Transpl ; 18(1): 87-90, 2007 Mar.
Article En | MEDLINE | ID: mdl-17237898

Xanthogranulomatous pyelonephritis (XPN) is a rare form of chronic pyelonephritis, which is usually caused by calculous obstructive uropathy. We present a previously healthy 45-year-old housewife, who was admitted to The Dammam Central Hospital, Dammam, Saudi Arabia with left loin pain and increased frequency of micturition of four days duration. She also had icterus and features of disseminated intravascular coagulation. Abdominal ultrasound and computed tomography of the abdomen was suggestive of XPN. She responded well to treatment with antibiotics and nephrectomy. Histology of the resected kidney confirmed a diagnosis of XPN. Our case suggests that the diagnosis of XPN should be kept in mind when a middle-aged female patient presents with unilateral non-functioning hydronephrotic kidney, which is totally distorted, and has enhancing as well as non-enhancing regions on computed tomography.


Pyelonephritis, Xanthogranulomatous/complications , Pyelonephritis, Xanthogranulomatous/diagnosis , Ureteral Calculi/complications , Diagnosis, Differential , Disseminated Intravascular Coagulation/etiology , Disseminated Intravascular Coagulation/pathology , Escherichia coli/isolation & purification , Female , Flank Pain/etiology , Flank Pain/pathology , Humans , Jaundice/etiology , Jaundice/pathology , Middle Aged , Pyelonephritis, Xanthogranulomatous/etiology , Pyelonephritis, Xanthogranulomatous/microbiology , Pyelonephritis, Xanthogranulomatous/pathology , Pyonephrosis/microbiology , Ureteral Calculi/diagnosis , Ureteral Calculi/pathology
19.
Khirurgiia (Mosk) ; (11): 40-3, 2006.
Article Ru | MEDLINE | ID: mdl-17159876

Results of complex treatment of 46 patients with large necrotic and purulent lesions of soft tissues with plasma technology are analyzed. In "short-distance coagulation" regimen high-energy argon and air-plasma flows were successfully used at final stage of surgical treatment of suppurative focus. Number of consecutive necrectomies and intraoperative hemorrhage has been significantly reduced. Plasma flow in "therapy" regimen accelerated regeneration and epithelization of the wound. Advantage of plasma technologies was also confirmed by the data of microbiological, cytological and histological studies. The developed method and algorithm of treatment with a focus on specific clinical situation reduced lethality and hospital stay 1.5-fold.


Laser Coagulation/methods , Pyonephrosis/surgery , Soft Tissue Infections/surgery , Adult , Aged , Bacterial Infections/complications , Female , Humans , Male , Middle Aged , Pyonephrosis/microbiology , Severity of Illness Index , Soft Tissue Infections/microbiology
...